Dynavox Group (DYVOX) - Net Assets
Based on the latest financial reports, Dynavox Group (DYVOX) has net assets worth Skr367.00 Million SEK (≈ $39.50 Million USD) as of June 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr1.76 Billion ≈ $189.40 Million USD) and total liabilities (Skr1.39 Billion ≈ $149.91 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check DYVOX cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr367.00 Million |
| % of Total Assets | 20.85% |
| Annual Growth Rate | 78.4% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 84.08 |
Dynavox Group - Net Assets Trend (2019–2023)
This chart illustrates how Dynavox Group's net assets have evolved over time, based on quarterly financial data. Also explore how large is Dynavox Group's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for Dynavox Group (2019–2023)
The table below shows the annual net assets of Dynavox Group from 2019 to 2023. For live valuation and market cap data, see Dynavox Group market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | Skr297.80 Million ≈ $32.05 Million |
+41.41% |
| 2022-12-31 | Skr210.60 Million ≈ $22.66 Million |
+50.97% |
| 2021-12-31 | Skr139.50 Million ≈ $15.01 Million |
+1584.04% |
| 2020-12-31 | Skr-9.40 Million ≈ $-1.01 Million |
-131.97% |
| 2019-12-31 | Skr29.40 Million ≈ $3.16 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Dynavox Group's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 764.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Skr299.80 Million | 100.67% |
| Common Stock | Skr500.00K | 0.17% |
| Other Comprehensive Income | Skr-2.50 Million | -0.84% |
| Total Equity | Skr297.80 Million | 100.00% |
Dynavox Group Competitors by Market Cap
The table below lists competitors of Dynavox Group ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Alarko Holding AS
IS:ALARK
|
$930.89 Million |
|
Jiangsu Huaxicun Co Ltd
SHE:000936
|
$930.90 Million |
|
Dalian Insulator Group Co Ltd
SHE:002606
|
$930.99 Million |
|
VNDIRECT Securities Corp
VN:VND
|
$931.19 Million |
|
Morguard Corporation
TO:MRC
|
$930.79 Million |
|
Zhejiang Xinao Textiles Inc
SHG:603889
|
$930.73 Million |
|
Xvivo Perfusion AB
ST:XVIVO
|
$930.17 Million |
|
Sensirion Holding AG
SW:SENS
|
$930.10 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Dynavox Group's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 210,600,000 to 297,800,000, a change of 87,200,000 (41.4%).
- Net income of 104,100,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 21,900,000.
- Other factors increased equity by 5,000,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr104.10 Million | +34.96% |
| Other Comprehensive Income | Skr-21.90 Million | -7.35% |
| Other Changes | Skr5.00 Million | +1.68% |
| Total Change | Skr- | 41.41% |
Book Value vs Market Value Analysis
This analysis compares Dynavox Group's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 29.32x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 278.19x to 29.32x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | Skr0.29 | Skr81.95 | x |
| 2020-12-31 | Skr0.29 | Skr81.95 | x |
| 2021-12-31 | Skr1.39 | Skr81.95 | x |
| 2022-12-31 | Skr2.00 | Skr81.95 | x |
| 2023-12-31 | Skr2.79 | Skr81.95 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Dynavox Group utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 34.96%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.45%
- • Asset Turnover: 0.95x
- • Equity Multiplier: 5.70x
- Recent ROE (34.96%) is below the historical average (150.23%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 230.27% | 7.45% | 1.17x | 26.47x | Skr64.76 Million |
| 2020 | 441.50% | 14.50% | 1.22x | 24.88x | Skr126.86 Million |
| 2021 | 21.36% | 3.42% | 0.76x | 8.22x | Skr15.85 Million |
| 2022 | 23.08% | 4.00% | 0.92x | 6.28x | Skr27.54 Million |
| 2023 | 34.96% | 6.45% | 0.95x | 5.70x | Skr74.32 Million |
Industry Comparison
This section compares Dynavox Group's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $278,248,333
- Average return on equity (ROE) among peers: -54.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Dynavox Group (DYVOX) | Skr367.00 Million | 230.27% | 3.80x | $930.88 Million |
| ADDvise Group AB A (ADDV-A) | $3.30 Million | 33.40% | 2.57x | $4.23 Million |
| ADDvise Group B (ADDV-B) | $835.00 Million | 10.78% | 3.13x | $108.58 Million |
| AddLife AB (publ) (ALIF-B) | $346.60 Million | 22.45% | 2.68x | $1.80 Billion |
| Biotage AB (BIOT) | $990.04 Million | 17.68% | 0.45x | $1.23 Billion |
| Bonesupport Holding AB (BONEX) | $34.30 Million | -321.22% | 4.50x | $1.56 Billion |
| iZafe Group AB Series B (IZAFE-B) | $40.73 Million | -89.06% | 0.19x | $14.83 Million |
| Ortivus AB ser. A (ORTI-A) | $22.41 Million | -97.60% | 2.16x | $322.08K |
| Ortivus AB ser. B (ORTI-B) | $224.47 Million | 5.79% | 0.15x | $14.04 Million |
| S2Medical AB (S2M) | $7.38 Million | -72.91% | 0.51x | $611.88K |
About Dynavox Group
Dynavox Group AB (publ), through its subsidiaries, engages in the development and sale of assistive technology products for customers with impaired communication skills. The company offers custom designed augmentative and alternative communication (AAC) solutions that enable people with disabilities, such as cerebral palsy, ALS, autism, and spinal cord injury, to communicate on their own. Its com… Read more